Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas

Kim, K.-S., Habashy, K., Gould, A., Zhao, J., Najem, H., Amidei, C., Saganty, R., Arrieta, V. A., Dmello, C., Chen, L., Zhang, D. Y., Castro, B., Billingham, L., Levey, D., Huber, O., Marques, M., Savitsky, D. A., Morin, B. M., Muzzio, M., … Sonabend, A. M. (2024). Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood–brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas. Neuro-Oncology, 26(11), 2044–2060. https://doi.org/10.1093/neuonc/noae135
Authors:
Kwang-Soo Kim
Karl Habashy
Andrew Gould
Hinda Najem
Christina Amidei
Ruth Saganty
Victor A. Arrieta
Crismita Dmello
Li Chen
Daniel Y. Zhang
Brandyn Castro
Leah Billingham
Craig Horbinski
Peng Zhang
Jason Miska
Amy B. Heimberger
Roger Stupp
Catalina Lee-Chang
Adam M. Sonabend
Junfei Zhao
Raul Rabadan
Daniel Levey
Olivia Huber
Marilyn Marques
David A. Savitsky
Benjamin M. Morin
Dhan Chand
Miguel Muzzio
Michael Canney
Surya Padney
Bin Zhang
Joanna J. Phillips
Nicholas Butowski
Jian Hu
Affiliated Authors:
Junfei Zhao
Raul Rabadan
Columbia Affiliation:
Author Keywords:
bbb
doxorubicin
fc-enhanced anti-ctla-4
glioblastoma
immunotherapy
elink
Publication Type:
Article
Unique ID:
10.1093/neuonc/noae135
PMID:
39028616
DOI:
10.1093/neuonc/noae135
Journal:
Neuro-Oncology
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record

Record Created: